. 2017 Sep 12;6(8):595–600. doi: 10.1530/EC-17-0130
This work is licensed under a Table 1.
Characteristics of patients from the two treatment groups.
| Characteristics | NIFE + RESV (n = 174) | NIFE + placebo (n = 175) | P value |
|---|---|---|---|
| Maternal age (year) | 27.1 ± 6.2 | 26.9 ± 7.1 | 0.41 |
| Gestation age (week) | 34.7 ± 3.4 | 33.4 ± 4.1 | 0.52 |
| Systolic blood pressure (mmHg) | 169.1 ± 15.2 | 171.4 ± 16.1 | 0.28 |
| Diastolic blood pressure (mmHg) | 107.9 ± 9.6 | 112.4 ± 10.1 | 0.13 |
| Heart rate (/min) | 84.1 ± 10.2 | 86.4 ± 9.4 | 0.27 |
| Body weight (kg) | 64.8 ± 3.6 | 63.1 ± 4.8 | 0.31 |
| Body height (m) | 1.67 ± 0.12 | 1.65 ± 0.11 | 0.20 |
| BMI (kg/m2) | 23.5 ± 3.1 | 24.4 ± 3.8 | 0.37 |
BMI, body mass index; NIFE, nifedipine; RESV, resveratrol.